Aug 14, 2020
Lupin Presents Phase 3 Data for Solosec® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Jun 11, 2020
Lupin Pharmaceuticals and PlushCare Expand Access to Bacterial Vaginosis (BV) Treatment to Help Meet Patient Needs During COVID-19 Pandemic
Jun 09, 2020
Ceek and Lupin Sign a Marketing Agreement to Improve OB/GYN and Patient Exam Experience with the Nella® Products
Jun 09, 2020
Lupin Signs Marketing Agreement With Ceek for Women's Health Products to Improve OB/GYN and Patient Exam Experience
May 04, 2020
Lupin Announces Positive Topline Results From its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis
Apr 22, 2020
Lupin Announces SOLOSEC® (secnidazole) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.
Apr 09, 2020
Infant Fecal pH Revealed as a Critical Indicator of Infant Gut Health and Resistance against Gut Pathogen Invasion
Mar 06, 2020
$1.87 Billion Mycoplasma Testing Market Insights, 2020-2027 - Cell Line Testing Anticipated to Exhibit the Highest CAGR
Dec 23, 2019
Global Mycoplasma Testing Market Analysis, Competitive Landscape, Growth Trends, and Forecasts 2019-2024 - ResearchAndMarkets.com
Nov 06, 2019
NxGen MDx announces Urogenital Pathogens Tests with a turnaround of 24 hours
Oct 29, 2019
Mycoplasma Testing Market to Reach USD 1.42 Billion by 2026 | Reports And Data
Sep 30, 2019
BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria
Aug 06, 2019
LUCA Biologics Launches to Develop Live Biotherapeutics for Women's Health Starting with Urinary Tract Infection (UTI)
Feb 25, 2019
SutroVax Announces Publication of Preclinical Proof of Concept for Preventive Vaccine for Periodontal Disease
Nov 26, 2018
Okayama University Research: Insights into Mechanisms Governing the Resistance to the Anti-cancer Medication Cetuximab
Oct 10, 2018
UC Davis Scientific Team Strengthens Case for Bifidobacterium in the Fight Against Antibiotic Resistance
Oct 09, 2018
Data on Patient Acceptability and Genitourinary Effects of Evofem Biosciences' Lead Product Candidate, Amphora, and its Role as a Multipurpose Vaginal pH Regulator Presented at 2018 American Society of Reproductive Medicine Annual Congress
Sep 21, 2018
New Data on Patient Acceptability and Genitourinary Effects of Evofem Biosciences' Amphora and its Role as a Multipurpose Vaginal pH Regulator (MVP-R) to be Presented at the 2018 American Society For Reproductive Medicine (ASRM) Annual Congress
Sep 06, 2018
Research Shows Probiotics Helpful in Preventing Bacterial Vaginosis
Mar 20, 2018
Coriell Life Sciences Teams with Quantigen Genomics to Transform the Detection of Vaginal Infections